NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc.

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...

Viatris issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods. The most recent guidance for Viatris (VTRS) was reported ...

Despite the more favorable entry price, we're cautious about Viatris. Here are three reasons why there are better opportunities than VTRS and a stock we'd rather own. Formed in 2020 through the ...

Viatris (VTRS) is expected to deliver a year-over ... estimates is a powerful factor that could impact its near-term stock price. The earnings report, which is expected to be released on February ...

We would stay out of VTRS stock. Conservative Income Portfolio members ... VTRS attributed this to changes in government price regulations and reimbursement policies. Greater China was a welcome ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against the other ...